Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

How much have NHS prescriptions increased to and who doesn't have to pay?

Pharmacists are concerned the recent rise in the cost of NHS drugs will mean more people won’t be able to afford all the medication they need

Evening Standard

3 Top Pharma Stocks for May 2024

The pharmaceutical sector is experiencing rapid growth, driven by the ever-rising healthcare needs and the adoption of advanced technologies. Against this backdrop, fundamentally strong pharmaceutical stocks such as Teva Pharmaceutical Industries (TEVA), Neurocrine Biosciences (NBIX), and GSK plc (GSK) could be solid portfolio additions for May. Read on.

StockNews.com

AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales

Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Deciphera Catapults 73% On Ono Pharmaceutical's $2.4 Billion Takeover

Deciphera stock rocketed to a three-year high Monday after Ono Pharmaceutical agreed to buy it for $2.4 billion.

Investors Business Daily

Revealed: UK government was warned of infected blood risks in 1970s

Documents show officials were told blood plasma harvested from US convicts was contaminated with viruses

The Guardian - UK

‘Plasma was called liquid gold’: the true story of the UK infected blood scandal

Documents examined by inquiry show officials knew people were being given infected blood products, but sanctioned their use

The Guardian - UK

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed

ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure

The FDA approved Pfizer's hemophilia gene therapy on Friday. But Pfizer stock only inched ahead on the approval early Friday.

Investors Business Daily

Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again

Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.

Investors Business Daily

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market

Novartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.

Investors Business Daily

AstraZeneca's £18.7m boss Soriot bounces back as pharma giant reveals 18% sales growth

Soriot came under fire this month for his £18.7 million pay packet

Evening Standard

IBD Stock Of The Day Medpace Flirts With Breakout After Big Earnings Reversal

Medpace is Wednesday's IBD Stock Of The Day. Medpace stock reversed Tuesday after a mixed first-quarter report.

Investors Business Daily

Weight Loss Leader Novo Nordisk Hits Buy Trigger In Stock Market Rebound

Novo Nordisk stock: The weight-loss drug leader hit a buy point in the recent stock market rebound and is one of the best stocks to watch.

Investors Business Daily

Biogen Stock Surges After Two Notable Products Walloped Sales Expectations

Two of Biogen's newest drugs walloped first-quarter sales expectations on Wednesday, and helped Biogen stock jump.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - AU

Experts warn of influx of synthetic opioids amid calls for second Melbourne injecting room

Use of deadly nitazines is on the rise in Australia and a suite of measures is needed to prevent more fatalities, former New Zealand prime minister Helen Clark says

The Guardian - UK

People with MND in England and Wales fear losing access to life-extending drug

NHS cost threshold has not been raised by National Institute for Health and Care Excellence since 2004

Investors Business Daily

The Bad News Heading Into AbbVie's First-Quarter Earnings Report

AbbVie stock has slumped 9% off its record high in March and is facing increasingly steep competition for its biggest moneymaker, Humira.

Investors Business Daily

How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher

ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

How Ewing Kauffman Built A Pharma Giant

Kauffman had built Marion Labs into a solid pharmaceutical business. To reach the next level, he knew he needed to take risks.

International Business Times

Exploring The Powerful Benefits Of Natural Health Products Made With Cutting-Edge Science

In a post-COVID world, society is branching away from pharmaceutical medicine and seeking support that may be less likely to cause side effects.

Investors Business Daily

Biotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point

Intra-Cellular stock: Shares rocketed more than 23% Tuesday, sending them past their latest buy point on the stock market today.

StockNews.com

JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…

Investors Business Daily

Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

Neumora said Monday the FDA put its schizophrenia drug on hold after rabbits experienced convulsions, and the biotech stock plunged.

Investors Business Daily

Nvidia Leads 5 Stocks Near Buy Points As S&P 500 Tests Key Level

Nvidia, which bucked the S&P 500 downdraft last week, leads this weekend's watch list of five stocks near buy points.

The Guardian - UK

The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca

Despite rebellion, approval of £18.7m package opens door to likelihood of US-style executive pay elsewhere

1 … 16 17 18 19

People

Margaret Kaczor Andrew

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.